血尿酸降低对2型糖尿病早期肾损伤的诊断价值

2005-02-021.2.2016001964-.1000-2200200601-0087-02211122832UAU-mALBβ2U-β2M2U-β2MU-mALBP0.05P0.012R587.1R692AUA12832UAU-mALBβ2U-β2M11.18320031～62473660.5±12.0422140～801.2RocheRochePrecinormPrecipathBeckmen7060U-mALBU-β2MELISADENLEYDRAGONWellscanMK2ThermoLabsystemsWellwash1.3U-mALBU-β2M83241U-β2MU-mALBU-β2M0.3mg/LU-mALB,20mg/L2U-β2MU-mALBU-β2M0.3mg/LU-mALB20mg/L3U-mALBU-β2MU-mALB20mg/LU-β2M0.3mg/L4U-mALBU-β2MU-β2M0.3mg/LU-mALB20mg/L51.4q215UA2P0.05P0.01112UAx±sµmol/LnUAFPMS132292.50±101.84216217.35±57.64**.312286.25±66.383.880.019036.81423295.96±144.07542326.90±71.22q5**P0.0121.P0.053223β2M4U-mALB512P0.05U-β2MU-mALB212U-mALBU-β2M7820061311UAUAU-β2MU-mALBUAU-mALBU-β2MUA2UA21.J.2000186380-381.2.J.1997226431-433.3.J.2000252100-101.4.J.2003269562-564.5.J.200344275-276.2005-02-162410011970.1000-2200200601-0088-02K-B1448125/R378R453A1311.120011～200410240695839.8%144860.2%144873951.0%41728.8%22515.5%674.7%ATCC25922ATCC278531.2API20EAPI20NE1.3NCCLSβ-ESBLs//NCCLS200222.1144889761.9%55138.1%539427.2%23216.0%23015.9%20113.9%1319.1%14481212.2ESBLs624192ESBLs30.8%39415038.1%2304218.3%ESBLsESBLs1288JBengbuMedCollJanuary2006Vol.31No.1